Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability. - Ayyadevara VSSA; Perencsik R; Patil S; Gaur S; Paik A; Toma M; Wertheim G; Geng H; Skorski T; Swaminathan S; Hurtz C (Leukemia, 2026)